中国新型商业保险模式有望扩大阿尔茨海默病药物可及性
China's new commercial insurance model could broaden access to Alzheimer's drugs
生命科学资讯
生物技术与制药领域的最新动态
百时美施贵宝就药品定价争议上诉至最高法院。
Bristol Myers brings IRA drug pricing fight to Supreme Court
10x Genomics股票为何突然飙升——来自TipRanks的分析
Why 10x Genomics Stock Is Suddenly Surging - TipRanks
2025年12月15日至19日医疗科技股涨跌榜
Med-tech gainers and losers for Dec. 15-19, 2025
美国指控六人涉嫌内幕交易，案件涉及奥莱玛肿瘤公司
US charges six people with insider trading in case including Olema Oncology
2025年12月22日融资信息
Financings for Dec. 22, 2025
(Shíyè jiāng wǎn)
In the clinic for Dec. 22, 2025
2025年12月22日其他新闻要点
Other news to note for Dec. 22, 2025
(Shǎo yè 22, 2025 de guān lǐ xíng xíng)
Regulatory actions for Dec. 22, 2025
FDA批准Cytokinetics公司a药Myqorzo用于oHCM治疗。
FDA says yes to Cytokinetics’ aficamten, now Myqorzo, in oHCM
10x Genomics (TXG) 股价上涨，原因如下 - 雅虎财经
10x Genomics (TXG) Stock Trades Up, Here Is Why - Yahoo Finance
10x Genomics (TXG) 股价上涨，原因如下 - TradingView — 追踪所有市场动态
10x Genomics (TXG) Stock Trades Up, Here Is Why - TradingView — Track All Markets
10x Genomics (TXG) 股价上涨，原因如下 - FinancialContent
10x Genomics (TXG) Stock Trades Up, Here Is Why - FinancialContent
与Markus Vossman探讨基因组学、NGS技术及其利大于弊的影响——pharmaphorum专访
On genomics, NGS, and doing much more good than bad, with Markus Vossman - pharmaphorum
Aktis获大型药企支持，计划通过IPO融资推进放射性药物试验
Big Pharma-backed Aktis plans IPO to fund radiopharma trials
勃林格殷格翰为Rectify的ABC肾病项目规划4.48亿美元未来蓝图
Boehringer spells out a $448M future for Rectify's ABC kidney disease program
豪洛捷乳腺癌研究强化乳腺X光AI应用价值
Hologic breast cancer study bolsters use of mammogram AI
编者按：激烈医疗科技2025年十大故事揭示科技如何疗愈
Editor's corner: Fierce Medtech's top 10 stories of 2025 show how tech can treat
吉利德斥资3500万美元从Assembly Bio协议中获取一对HSV资产许可。
Gilead pays $35M to license pair of HSV assets from Assembly Bio pact
Illumina公司是否正在获得或失去市场支持？ - Benzinga
Is Illumina Inc Gaining or Losing Market Support? - Benzinga